Back Login for AI Analysis

    DNLI (STOCKS)

    Denali Therapeutics Inc. Common Stock

    $19.750000
    +0.520000 (+2.70%)
    Prev close: $19.230000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Biotechnology
    CEO
    Ryan J. Watts
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $3,078.26M
    Employees
    517
    P/E (TTM)
    -6.48
    P/B (TTM)
    2.96
    Dividend Yield
    —
    Technical Indicators
    SMA 10
    —
    SMA 20
    —
    SMA 50
    —
    EMA 9
    —
    EMA 21
    —
    RSI
    —
    MACD State
    —
    Analyst Recommendations
    11
    Strong Buy
    12
    Buy
    2
    Hold
    0
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Dec 2025 (Q4)
    		 $-0.73 $-0.76 +0.0290 +3.82%
    Sep 2025 (Q3)
    		 $-0.74 $-0.77 +0.0269 +3.51%
    Jun 2025 (Q2)
    		 $-0.72 $-0.73 +0.0138 +1.88%
    Mar 2025 (Q1)
    		 $-0.78 $-0.70 -0.0800 -11.43%
    Financial Statements
    TTM (Dec 2025)
    Revenues $0.00
    Operating Expenses $555.34M
    Research and Development $418.78M
    Other Operating Expenses $136.56M
    Operating Income/Loss -$555.34M
    Income/Loss From Continuing Operations After Tax -$512.54M
    Income/Loss From Continuing Operations Before Tax -$512.44M
    Income Tax Expense/Benefit $102.00K
    Income Tax Expense/Benefit, Current $102.00K
    Income Tax Expense/Benefit, Deferred $0.00
    Net Income/Loss -$512.54M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent -$512.54M
    Net Income/Loss Available To Common Stockholders, Basic -$512.54M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Basic Earnings Per Share -$2.97
    Diluted Earnings Per Share -$2.97
    Basic Average Shares 172,649,097
    Diluted Average Shares 172,649,097
    Assets $1.14B
    Current Assets $900.66M
    Noncurrent Assets $244.20M
    Fixed Assets $52.40M
    Other Non-current Assets $191.79M
    Liabilities $131.09M
    Current Liabilities $98.35M
    Accounts Payable $3.33M
    Wages $32.18M
    Other Current Liabilities $62.84M
    Noncurrent Liabilities $32.74M
    Equity $1.01B
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $1.01B
    Liabilities And Equity $1.14B
    Net Cash Flow From Operating Activities -$412.60M
    Net Cash Flow From Operating Activities, Continuing -$412.60M
    Net Cash Flow From Investing Activities $255.28M
    Net Cash Flow From Investing Activities, Continuing $255.28M
    Net Cash Flow From Financing Activities $189.22M
    Net Cash Flow From Financing Activities, Continuing $189.22M
    Net Cash Flow $31.90M
    Net Cash Flow, Continuing $31.90M
    Comprehensive Income/Loss -$513.88M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$513.88M
    Other Comprehensive Income/Loss -$513.88M
    Other Comprehensive Income/Loss Attributable To Parent -$1.34M
    Related Companies
    BEAM